Myeong-Jae Park
Corporate Officer/Principal at CHA University
Network origin in Myeong-Jae Park first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
CHA University
5
| College/University | Other Consumer Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Myeong-Jae Park via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CHABIOTECH CO.,LTD. | Electronic Components | President | |
| Konkuk University | College/University | Doctorate Degree | |
CHA Health Systems, Inc.
 CHA Health Systems, Inc. Medical/Nursing ServicesHealth Services Part of Cha Biotech Co., Ltd., CHA Health Systems, Inc. is a leader in the biotechnology industry. The company is based in Los Angeles, CA. CHA Health Systems delivers world-class care in all facets of medicine, with a focus on fertility and cutting-edge therapies using cord blood stem cells and immune cells. The company is known for their research and clinical work in these fields. CHA Health Systems consists of 81 hospitals and clinics, 30 research and 14 education institutions, and 31 bio/pharmaceutical/healthcare companies in seven countries. The CEO of the company is Yong-Seok Kim. | Medical/Nursing Services | Chief Executive Officer | |
Stem Cell & Regenerative Medicine International, Inc.
 Stem Cell & Regenerative Medicine International, Inc. Pharmaceuticals: MajorHealth Technology Stem Cell & Regenerative Medicine International, Inc. engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company is headquartered in Marborough, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| THERAGEN ETEX CO.,LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Tsukuba | College/University | Doctorate Degree | |
| MEDPACTO, INC. | Pharmaceuticals: Major | Founder | |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Biotechnology | Founder | |
| NEXEN TIRE CORPORATION | Automotive Aftermarket | Director/Board Member | |
| Yonsei University | College/University | Doctorate Degree | |
| PAPERCOREA INC. | Pulp & Paper | Director/Board Member | |
| CARELABS CO.,LTD | Packaged Software | Director/Board Member | |
| VT CO., LTD. | Household/Personal Care | Director/Board Member | |
| HYUNDAI BIOLAND CO.,LTD. | Chemicals: Major Diversified | Director/Board Member |
Statistics
International
| South Korea | 11 |
| United States | 4 |
| Japan | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Process Industries | 3 |
| Electronic Technology | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 12 |
| Independent Dir/Board Member | 6 |
| Corporate Officer/Principal | 5 |
| Doctorate Degree | 3 |
| Chief Executive Officer | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Hyung-Min Chung | 5 |
| Seong-Jin Kim | 5 |
| Tae-Joon Jeon | 5 |
| Kwang-Hyun Baek | 2 |
| Kwang-Hyun Koh | 2 |
- Stock Market
- Insiders
- Myeong-Jae Park
- Company connections
